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Supplementary information: 
Figure 1. Lipid accumulation in differentiating 3T3-F442A and human primary 
adipocytes following incubation with serial concentrations of protease inhibitors. Lipid 
accumulation was estimated by a colorimetric adipogenesis assay after Oil Red O staining in 
differentiating 3T3-F442A (Fig 1A) and human primary adipocytes (Fig 1B). Data expressed 
as mean (n=5) ± SD. *=P<0.01; Drug v Vehicle.  
 
Figure 1A: 3T3-F442A adipocytes 
 
 
 
 
 
 
 
 
 
Figure 1B: Human primary adipocytes 
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Figure 2: Expression of PPARγ (2A and 2B) and LPIN1 (2C and 2D) mRNA in 
differentiating 3T3-F442A and human primary adipocytes following treatment with 
serial concentrations of protease inhibitors. Relative gene expression was assessed by Real 
Time PCR and is presented as ΔΔCt. Data expressed as mean (n=5) ± SD. *=P<0.01; Drug v 
Vehicle. †=P<0.01; Preadipocyte v Vehicle. Preadipo: preadipocyte; Veh: vehicle; LPV: 
lopinavir; RTV: ritonavir; ATV: atazanavir.  
 
2A) PPARγ expression in 3T3-F442A 
 
 
 
 
 
 
 
 
 
 
2B) PPARγ expression in human primary adipocytes 
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 2C) LPIN1 expression in 3T3-F442A 
 
 
 
 
 
 
 
 
 
 
2D) LPIN1 expression in human primary adipocytes 
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Figure 3. Adipokine secretion in differentiating 3T3-F442A and human primary 
adipocytes following incubation with serial concentrations of protease inhibitors. 
Secreted adipokines (adiponectin [3A & 3B]; IL-6 [3C & 3D]; TNFα [3E & 3F]; resistin [3G 
& 3H]) in the conditioned media following incubation of adipocytes with protease inhibitors 
was determined by Bead-based multiplex or singleplex ELISA. Data expressed as mean 
(n=5) ± SD. *=P<0.01; Drug v Vehicle. †=P<0.01; Preadipocyte v Vehicle. Preadipo: 
preadipocyte; Veh: Vehicle; RTV: ritonavir; LPV: lopinavir; ATV: atazanavir; IL-6: 
Interleukin-6. TNFα: Tumor necrosis factor-α. 
 
Fig 3A: Secreted adiponectin in 3T3-F442A adipocytes 
 
 
 
 
 
 
 
 
 
 
 
Fig 3B: Secreted adiponectin in human primary adipocytes 
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Fig 3C: Secreted IL-6 in 3T3-F442A adipocytes 
 
 
 
 
 
 
 
 
 
 
 
Fig 3D: Secreted IL-6 in human primary adipocytes 
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Fig 3E: Secreted TNF-α in 3T3-F442A adipocytes 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3F: Secreted TNF-α in human primary adipocytes 
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Fig 3G: Secreted resistin in 3T3-F442A adipocytes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3H: Secreted resistin in human primary adipocytes 
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Figure 4. Expression of pAktSer473 in differentiating human primary adipocytes 
following incubation with serial concentrations of protease inhibitors. Protein expression 
was determined from whole adipocyte cell lysate by sandwich ELISA (pAkt and Total Akt). 
Data expressed as mean ratio of absorbance (pAkt expression adjusted to Total Akt) (n=5) ± 
SD. *=P<0.01; Drug v Vehicle. Veh: Vehicle; RTV: ritonavir; LPV: lopinavir; ATV: 
atazanavir. 
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